Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization

Cellular and Molecular Immunology

Volumn 13, Issue 2, 2016, Pages 251-262

  Kozakova, Hana ^a   Schwarzer, Martin ^a   Tuckova, Ludmila ^a   Srutkova, Dagmar ^a   Czarnowska, Elzbieta ^b   Rosiak, Ilona ^b   Hudcovic, Tomas ^a   Schabussova, Irma ^c   Hermanova, Petra ^a   Zakostelska, Zuzana ^a   Aleksandrzak Piekarczyk, Tamara ^d   Koryszewska Baginska, Anna ^d   Tlaskalova Hogenova, Helena ^a   Cukrowska, Bozena ^b  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

allergic sensitization; germ free; intestinal barrier; Lactobacillus; probiotics

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; POLLEN ANTIGEN; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; BET V 1 ALLERGEN, BETULA; CARD15 PROTEIN, MOUSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NOD2 PROTEIN, HUMAN; PLANT ANTIGEN; TLR2 PROTEIN, HUMAN; TLR2 PROTEIN, MOUSE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BONE MARROW DERIVED DENDRITIC CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GERMFREE MOUSE; GNOTOBIOTICS; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LYMPH NODE CELL; MOUSE; NONHUMAN; SPECIES DIFFERENCE; SPLEEN CELL; STRAIN DIFFERENCE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; GERMFREE ANIMAL; HEK293 CELL LINE; HYPERSENSITIVITY; IMMUNOLOGY;

ANIMALS; ANTIGENS, PLANT; GERM-FREE LIFE; HEK293 CELLS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED BALB C; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTOR 2;

EID: 84959880260     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.09     Document Type: Article

References (56)

1. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474: 298-306.
2. Tlaskalova-Hogenova H, Sterzl J, Stepankova R, Dlabac V, Veticka V, Rossmann P et al. Development of immunological capacity under germfree and conventional conditions. Ann NY Acad Sci 1983; 409: 96-113.
3. Perrier C, Corthesy B. Gut permeability and food allergies. Clin Exp Allergy 2011; 41: 20-28.
4. van Ree R, Hummelshoj L, Plantinga M, Poulsen LK, Swindle E. Allergic sensitization: host-immune factors. Clin Transl Allergy 2014; 4: 12.
5. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420.
6. Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011; 8: 110-120.
7. Penders J, Gerhold K, Stobberingh EE, Thijs C, Zimmermann K, Lau S et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 2013; 132: 601-607.
8. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
9. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
10. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy 2014; 44: 842-850.
11. Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 2011; 89: 685-695.
12. Lodinova-Zadnikova R, Cukrowska B, Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003; 131: 209-11.
13. Forsberg A, Abrahamsson TR, Bjorksten B, Jenmalm MC. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy 2013; 43: 434-442.
14. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol 2009; 44: 26-46.
15. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008; 14: 1585-1596.
16. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
17. Konieczna P, Groeger D, Ziegler M, Frei R, Ferstl R, Shanahan F et al. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012; 61: 354-366.
18. Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009; 4: e7056.
19. Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B et al. Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 2009; 64: 406-414.
20. Schwarzer M, Srutkova D, Schabussova I, Hudcovic T, Akgun J, Wiedermann U et al. Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1. Vaccine 2013; 31: 5405-5412.
21. Schabussova I, Hufnagl K, Tang ML, Hoflehner E, Wagner A, Loupal G et al. Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One 2012; 7: e40271.
22. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008; 28: 468-476.
23. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014; 133: 621-631.
24. Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, Chichester K, Myers L, Halushka MK et al. TGFbeta receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med 2013; 5: 195ra94.
25. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 2014; doi: 10.1111/cea.12332.
26. Wiedermann U. Hitting the mucosal road in tolerance induction. Nestle Nutr Workshop Ser Pediatr Program 2009; 64: 63-72.
27. Schabussova I, Hufnagl K, Wild C, Nutten S, Zuercher AW, Mercenier A et al. Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization. Vaccine 2011; 29: 1981-1990.
28. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains? J Nutr 2011; 50: 1-17.
29. Hansen CH, Nielsen DS, Kverka M, Zakostelska Z, Klimesova K, Hudcovic T et al. Patterns of early gut colonization shape future immune responses of the host. PLoS One 2012; 7: e34043.
30. Cukrowska B, Motyl I, Kozakova H, Schwarzer M, Gorecki RK, Klewicka E et al. Probiotic Lactobacillus strains: in vitro and in vivo studies. Folia Microbiol 2009; 54: 533-537.
31. Cukrowska B, Rosiak I, Klewicka E, Motyl I, Schwarzer M, Libudzisz Z et al. Impact of heat-inactivated Lactobacillus casei and Lactobacillus paracasei strains on cytokine responses in whole blood cell cultures of children with atopic dermatitis. Folia Microbiol 2010; 55: 277-280.
32. Aleksandrzak-Piekarczyk T, Koryszewska-Baginska A, Bardowski J. Genome sequence of the probiotic strain Lactobacillus rhamnosus (formerly Lactobacillus casei) LOCK900. Genome Announc 2013; 1: 00640-13.
33. Koryszewska-Baginska A, Bardowski J, Aleksandrzak-Piekarczyk T. Genome sequence of the probiotic strain Lactobacillus rhamnosus (formerly Lactobacillus casei) LOCK908. Genome Announc 2014; 2: 00120-14.
34. Koryszewska-Baginska A, Aleksandrzak-Piekarczyk T, Bardowski J. Complete genome sequence of the probiotic strain Lactobacillus casei (formerly Lactobacillus paracasei) LOCK919. Genome Announc 2013; 1: e00758-13.
35. Repa A, Kozakova H, Hudcovic T, Stepankova R, Hrncir T, Tlaskalova-Hogenova H et al. Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol Lett 2008; 117: 50-56.
36. Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H et al. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006; 61: 812-819.
37. Cinova J, de Palma G, Stepankova R, Kofronova O, Kverka M, Sanz Y et al. Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PloS One 2011; 6: e16169.
38. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675.
39. Wiedermann U, Jahn-Schmid B, Bohle B, Repa A, Renz H, Kraft D et al. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy. The J Allergy Clin Immunol 1999; 103: 1202-1210.
40. Wiedermann U, Herz U, Baier K, Vrtala S, Neuhaus-Steinmetz U, Bohle B et al. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int Arch Allergy Immunol 2001; 126: 68-77.
41. Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B et al. Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 2011; 66: 368-375.
42. Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 2010; 140: 713S-721S.
43. Lim LH, Li HY, Huang CH, Lee BW, Lee YK, Chua KY. The effects of heat-killed wild-type Lactobacillus casei Shirota on allergic immune responses in an allergy mouse model. Int Arch Allergy Immunol 2009; 148: 297-304.
44. Hisbergues M, Magi M, Rigaux P, Steuve J, Garcia L, Goudercourt D et al. In vivo and in vitro immunomodulation of Der p 1 allergenspecific response by Lactobacillus plantarum bacteria. Clin Exp Allergy 2007; 37: 1286-1295.
45. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatorydependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007; 37: 498-505.
46. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775-1785.
47. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr 2007; 137: 781S-790S.
48. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999; 69: 1046S-1051S.
49. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007; 2: e1308.
50. Jarvinen KM, Konstantinou GN, Pilapil M, Arrieta MC, Noone S, Sampson HA et al. Intestinal permeability in children with food allergy on specific elimination diets. Pediatr Allergy Immunol 2013; 24: 589-595.
51. Walker J, Dieleman L, Mah D, Park K, Meddings J, Vethanayagam D. High prevalence of abnormal gastrointestinal permeability in moderate-severe asthma. Clin Invest Med 2014; 37: E53-E57.
52. Jeon MK, Klaus C, Kaemmerer E, Gassler N. Intestinal barrier: molecular pathways and modifiers. World J Gastrointest Pathophysiol 2013; 4: 94-99.
53. Howe KL, Reardon C, Wang A, Nazli A, McKay DM. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol 2005; 167: 1587-1597.
54. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D et al. Bifidobacterial surface-exopolysaccharide facilitates commensalhost interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA 2012; 109: 2108-2113.
55. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 2011; 6: 261-274.
56. Gorska S, Schwarzer M, Jachymek W, Srutkova D, Brzozowska E, Kozakova H et al. Distinct immunomodulation of bone marrowderived dendritic cell responses to Lactobacillus plantarum WCFS1 by two different polysaccharides isolated from Lactobacillus rhamnosus LOCK 0900. Appl Environ Microbiol 2014; 80: 6506-6516.